Position in GSK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$47,797,918
+$14,371,267 QoQ
Shares Held
911,826
+50.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#48
of 1,033 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $648,972,761 across 12 Drug Manufacturers - General names. GSK ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
191,037 | $229,135,528 | |
| 2 | JNJ |
Johnson & Johnson
|
488,378 | $124,033,360 | |
| 3 | ABBV |
AbbVie Inc.
|
241,796 | $60,845,545 | |
| 4 | MRK |
Merck & Co., Inc.
|
468,644 | $60,220,754 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,033,357 | $59,542,030 | |
| 6 | GSK |
GSK plc
This page
|
911,826 | $47,797,918 | |
| 7 | AMGN |
Amgen Inc
|
63,977 | $23,167,351 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
181,413 | $22,919,718 |
All Filings in GSK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,797,918 | 911,826 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $33,426,651 | 605,665 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $41,896,392 | 854,331 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,728,816 | 40,056 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $4,655,961 | 121,249 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,663,409 | 94,564 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||